Edit |   |
---|---|
Antigenic Specificity | LINGO1, Human (Opicinumab biosimilar) |
Clone | Opicinumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human LINGO1 Recombinant Antibody. Opicinumab (BIIB033) is a fully human monoclonal antibody designed for the treatment of multiple sclerosis, acute optic neuritis (AON), and other associated demyelinating diseases. A biologic drug, it is designed to function as a LINGO-1 protein antagonist, known as ``Anti-Lingo-1''. |
Immunogen | n/a |
Other Names | Anti-LINGO1 Recombinant Antibody, Research Grade Opicinumab, Anti-Human LINGO1 Recombinant Antibody, BIIB-033, Antibody Drug Analogues, Monoclonal Antibody, YR1378, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1422268-07-2 |
Catalog # | YR1378 |
Price | please inquire |
Order / More Info | LINGO1, Human (Opicinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |